# Dynagrow Capital

> Dynagrow Capital is a VC fund backing Therapeutics, Biotechnology and Health Care. See 2 investments, round sizes, portfolio. Updated Oct 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Sep 2026
- Lead investor: 0%
- Last updated: Oct 2026

Dynagrow Capital is an investment firm and is an affiliate of Caret Group president Fred Hassan.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 2 | 100% |
| Biotechnology | 2 | 100% |
| Health Care | 1 | 50% |
| Pharmaceutical | 1 | 50% |
| Clinical Trials | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Astrocyte Pharmaceuticals | Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease. | $9.5M | Series B | Sep 30, 2026 | https://www.astrocytepharma.com/ |
| Myosin Therapeutics | Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders. The company specializes in molecular machines that turn energy into mechanical work inside cells, enabling doctors to treat various disease states, including cancer, and focuses on developing innovative drugs that target cellularmotor proteins. | $3M | Seed | Feb 26, 2025 | https://www.myosintherapeutics.com |

2 of 2 investments shown.

## Co-investors
- [DeepWork Capital](https://shizune.co/investors/profile/the-fan-fund) — VC Fund, 2 deals together
- [Angel Star Ventures](https://shizune.co/investors/profile/angel-star-ventures) — VC Fund, 1 deal together
- [Florida Opportunity Fund](https://shizune.co/investors/profile/florida-opportunity-fund) — VC Fund, 1 deal together
- [Mayo Clinic Ventures](https://shizune.co/investors/profile/mayo-clinic-ventures) — VC Fund, 1 deal together
- Mint12 Pharma — VC Fund, 1 deal together
- MintPharma Capital — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

## FAQ

### What does Dynagrow Capital invest in?

Dynagrow Capital invests primarily in Therapeutics, Biotechnology and Health Care startups, most often at Seed and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dynagrow Capital last invest?

The most recent investment recorded for Dynagrow Capital closed in Sep 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co